Thyroid cancer is known as "lazy cancer" and "the luckiest cancer" among the people. Is there any truth to this statement? In fact, it cannot be generalized, but must be analyzed in combination with the specific situation.

Overall, the prognosis of thyroid cancer is indeed relatively good, but there are great differences between different subtypes. The most common of them is papillary thyroid carcinoma, which is less malignant, with a 5-year survival rate and a 10-year survival rate of about 90%, and the treatment effect is much better than many other malignant tumors.

However, not all thyroid cancers are "mild". For example, medullary thyroid carcinoma and anaplastic thyroid carcinoma are relatively malignant, especially anaplastic thyroid carcinoma progresses rapidly, prone to local invasion and distant metastasis, and there is no effective treatment at present, and the one-year survival rate of patients is less than 20%.

Therefore, being diagnosed with thyroid cancer should not be taken lightly. Anaplastic thyroid carcinoma accounts for less than 2% of all thyroid cancers, and the incidence rate is relatively low. Most other thyroid cancers have good treatment results as long as they receive standardized diagnosis and treatment and adhere to follow-up and follow-up.

For highly malignant subtypes such as medullary thyroid carcinoma and anaplastic carcinoma, the treatment should not only rely on surgery, but also need to be combined with targeted therapy, chemotherapy, radiotherapy and other means to play a good "combination punch" in order to better control the disease.